Document is current
Any future updates will be listed below
-
Authors
Cakan-Akdogan, Gulcin
Erez, Ozlem
Ozer, Ceren
Onal, Ebru
Mert, Olcay
Gullu, Seyda
Arslan, Merve
Avci, Mehmet Ender
Inan, Mehmet
Kalyoncu, Sibel
-
Funding
Funding for this research was provided by:
VSY Biotechnology (IBG002, IBG002, IBG002, IBG002, IBG002, IBG002)
European Commission (RareBoost Project #952346)
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (119Z161, 119Z161, 119Z161)
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 10 July 2025
First Online: 31 July 2025
Declarations
:
: The three scFv molecules reported here were filed for patenting under PCT/TR2022/050990.
: Zebrafish experiments were conducted in embryos or larvae prior to independent feeding stage. According to EU Directive 2010/63, this stage is exempt from ethical regulations. All animal experimentation was conducted in accordance with EU Directive 2010/63 and national regulations. Animal experimental methods are reported in accordance with ARRIVE guidelines.
: The authors declare no competing interests.
